Skip to main content
Earnings Labs
MannKind Corporation logo

MannKind Corporation (MNKD)

NASDAQ·Healthcare·Biotechnology

$3.34

+1.52%

Mkt Cap $1.06B

Analyst Ratings

Buy

8

Hold

0

Sell

0

Price Target (14 analysts)

$10.00

Range $7.00 – $13.00

Implied Upside

+199.9%

Consensus $10.00 vs current $3.34